Seres Therapeutics News

Seres Therapeutics | 8-K: Current report

Sep 26 16:17 ET

Seres Therapeutics | DEFA14A: Others

Sep 12 08:34 ET

Seres Therapeutics | 8-K: Current report

Sep 12 07:10 ET

Seres Therapeutics | DEFM14A: Definitive proxy statement relating to merger or acquisition

Aug 26 16:41 ET

Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer DesRosier Thomas

Aug 19 17:53 ET

Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer von Moltke Lisa

Aug 19 17:48 ET

Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Henn Matthew R.

Aug 19 17:48 ET

Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Shaff Eric D.

Aug 19 17:43 ET

Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Young Teresa L.

Aug 19 17:38 ET

Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ege David S.

Aug 19 17:33 ET

Seres Therapeutics | DEFA14A: Others

Aug 15 16:08 ET

Seres Therapeutics | PREM14A: Preliminary proxy statements relating to merger or acquisition

Aug 15 06:57 ET

Seres Therapeutics | 8-K: Current report

Aug 15 06:18 ET

Seres Therapeutics | DEFA14A: Others

Aug 13 17:22 ET

Seres Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 13 10:42 ET

Seres Therapeutics | DEFA14A: Others

Aug 13 07:13 ET

Seres Therapeutics | 8-K: SERES THERAPEUTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

Aug 13 07:07 ET

Seres Therapeutics | DEFA14A: Others

Aug 7 13:56 ET

Seres Therapeutics | DEFA14A: Others

Aug 7 08:41 ET

Seres Therapeutics | DEFA14A: Others

Aug 6 17:33 ET